Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Rhea-AI Summary

Waters Corporation (NYSE:WAT) will report Q1 2026 results and host a conference call on May 5, 2026 at 8:30 a.m. ET.

A live webcast will be available on Waters Investor Relations, and a replay will remain available through at least June 2, 2026.

AI-generated analysis. Not financial advice.

News Market Reaction – WAT

-0.11%

1 alert

-0.11% News Effect

On the day this news was published, WAT declined 0.11%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings call date: May 5, 2026 Call time: 8:30 a.m. Eastern Time Webcast replay end: June 2, 2026 (midnight ET) +5 more

8 metrics

Earnings call date May 5, 2026 Q1 2026 financial results conference call

Call time 8:30 a.m. Eastern Time Scheduled start for Q1 2026 conference call

Webcast replay end June 2, 2026 (midnight ET) Replay availability for earnings call webcast

Employees ~16,000 colleagues Global Waters workforce cited in article

Current price $327.77 Pre-news market context for WAT

Daily move 2.74% Price change over prior 24 hours before this news

52-week range $275.05–$414.15 Low and high over the last 52 weeks

Shares outstanding 98,101,871 shares As of February 19, 2026 per S-3ASR shelf filing

Market Reality Check

Price: $355.53 Vol: Volume 438,802 is below t...

low vol

$355.53 Last Close

Volume Volume 438,802 is below the 20-day average of 893,104 (relative volume 0.49x). low

Technical Price $327.77 is trading below the 200-day MA of $335.87 and sits 20.86% under the 52-week high and 19.17% above the 52-week low.

Peers on Argus

WAT gained 2.74% with below-average volume while several diagnostics and lab-too...

WAT gained 2.74% with below-average volume while several diagnostics and lab-tool peers (DGX, ILMN, LH, MTD) also showed positive moves, but no coordinated sector momentum was flagged by the peer scanner.

Previous Conferences,earnings Reports

5 past events · Latest: Jan 20 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 20	Earnings call schedule	Neutral	-0.9%	Announced Q4 2025 results release date and conference call details.
Oct 01	Earnings call schedule	Neutral	+6.7%	Set timing and webcast info for Q3 2025 earnings conference call.
Jul 11	Earnings call schedule	Neutral	-13.8%	Outlined Q2 2025 earnings call date, time, and webcast replay window.
Apr 08	Earnings call schedule	Neutral	+9.4%	Announced Q1 2025 earnings call schedule and online access details.
Jan 17	Earnings call schedule	Neutral	-0.3%	Released schedule for Q4 2024 financial results conference call.

Pattern Detected

Prior earnings-call scheduling headlines produced mixed reactions, with single-day moves ranging from -13.81% to +9.36% and an average move of 0.19% across five events.

Recent Company History

Recent history for Waters shows a consistent cadence of scheduling quarterly earnings conference calls tagged as conferences,earnings, typically with modest price moves around the events. Prior notices for Q4 2025, Q3 2025, Q2 2025, Q1 2025, and Q4 2024 all followed the same pattern of announcing release dates, call times, and webcast access details. The current Q1 2026 call announcement continues this established communications approach without adding new financial metrics ahead of results.

Historical Comparison

+0.2% avg move · Past five earnings-call scheduling releases for WAT saw modest average moves of 0.19%, indicating th...

conferences,earnings

+0.2%

Average Historical Move conferences,earnings

Past five earnings-call scheduling releases for WAT saw modest average moves of 0.19%, indicating these notices have typically been low-impact trading catalysts.

The company has maintained a regular pattern of pre-announcing quarterly earnings calls (Q4 2024 through Q4 2025), and this Q1 2026 scheduling continues that established disclosure cadence.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2026-03-16

An automatic shelf registration on 2026-03-16 (Form S-3ASR) allows Waters and affiliates Augusta SpinCo Corporation and Waters Technologies Corporation to offer an indeterminate amount of securities, including equity and debt, from time to time, with certain affiliated debt guaranteed by Waters.

Market Pulse Summary

This announcement sets the timing for Waters’ Q1 2026 earnings call and webcast without disclosing n...

Analysis

This announcement sets the timing for Waters’ Q1 2026 earnings call and webcast without disclosing new financial figures. Historically, similar conferences,earnings notices produced mixed but generally modest price moves, with an average change of 0.19%. Investors may focus on how Q1 results reflect the integration of recently acquired businesses, capital-structure changes, and any updates following the effective shelf registration, while tracking execution against prior growth and margin trends.

Key Terms

diagnostics, informatics, antibiotic resistance

3 terms

diagnostics medical

"Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated"

Medical diagnostics are tests, tools, and systems that detect, measure, or monitor health conditions—like lab assays, imaging scans, or portable devices that tell whether someone has a disease or how well a treatment is working. For investors, diagnostics matter because they drive recurring revenue, influence healthcare decisions and treatment markets, and can make therapies more or less valuable; think of them as the sensors that guide where money and care get directed.

informatics technical

"through analytical technologies, informatics, and service."

Informatics is the practice of collecting, organizing and turning large sets of data into useful information using software and rules, often in fields like healthcare or business. For investors, it matters because better information systems act like a reliable map and traffic report for a company: they speed decision-making, reduce costly errors, improve product development and regulatory tracking, and can therefore influence revenue, costs and risk.

antibiotic resistance medical

"managing routine infections, and combating antibiotic resistance."

Antibiotic resistance is when bacteria change so that antibiotics no longer kill them or stop their growth, making common infections harder to treat. For investors, it is like tools in a toolbox losing effectiveness: it can raise healthcare costs, shorten the useful life of existing drugs, spur demand and regulatory scrutiny for new treatments and diagnostics, and therefore affect revenue, R&D spending and valuations across pharma, biotech and healthcare sectors.

AI-generated analysis. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least June 2, 2026, at midnight Eastern Time.

About Waters Corporation

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.

Caspar Tudor, Head of Investor Relations
investor_relations@waters.com

View original content:https://www.prnewswire.com/news-releases/waters-corporation-schedules-first-quarter-2026-earnings-conference-call-302747613.html

SOURCE Waters Corporation

FAQ

When is Waters Corporation (WAT) holding its Q1 2026 earnings call?

The Q1 2026 earnings call is scheduled for May 5, 2026 at 8:30 a.m. ET. According to the company, the live webcast of the presentation will be available on Waters Investor Relations for real-time access and investor listening.

How can I listen to the Waters (WAT) Q1 2026 webcast and where is it hosted?

You can listen via a live webcast on Waters Investor Relations at https://ir.waters.com. According to the company, the webcast will stream the conference presentation and provide direct access for investors and analysts.

Will Waters (WAT) provide a replay of the Q1 2026 earnings webcast and for how long?

A replay will be available until at least June 2, 2026 at midnight ET. According to the company, the replay ensures investors can review the presentation after the live call for several weeks.

What time zone is used for Waters Corporation's (WAT) May 5, 2026 earnings call?

The earnings call time is given in Eastern Time, starting at 8:30 a.m. ET on May 5, 2026. According to the company, all public scheduling and the webcast listing use Eastern Time for clarity.

Who should I contact for investor questions about Waters Corporation (WAT) Q1 2026 results?

For investor inquiries, contact Caspar Tudor, Head of Investor Relations, via the provided investor_relations@waters.com email. According to the company, this contact handles questions related to the earnings call and investor materials.